E-Cigarette Formaldehyde Exposure Greater When Voltage is Higher: Study

As concerns about the safety of e-cigarettes continues to mount, a new study suggests that people who use the electronic smoking devices at a high voltage may be exposed to a greater amount of formaldehyde, placing them at an increased risk of developing cancer. 

Researchers tested the output of formaldehyde from e-cigarette devices, finding that heating e-cig liquid at higher voltages allowed more formaldehyde to be released than at lower voltages. The findings were published in the New England Journal of Medicine on January 22.

E-cigarette liquid is typically a mixture of propylene glycol, glycerol, nicotine and flavoring chemicals.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Recently researchers have expressed concern about the risk of cancer that e-cigarette flavorings may pose, with a study published late last year detailing the risk chemicals like diacetyl 2,3-butanedione may pose to people inhaling the flavorings, such as bronchiolitis obliterans, commonly known as popcorn lung disease.

When e-cigarette liquid is heated, it forms a gas that users inhale. During this process the propylene glycol breaks down and formaldehyde hemiacetals, formaldehyde in droplet form, is also formed and released.

Researchers from Portland State University tested Halo brand nicotine liquid in a personal vaporizer heated at 3.3 volts and 5 volts. Consumers often will use a higher voltage to produce a stronger nicotine kick.

The liquid was tested at 10 puffs over five minutes each, lasting three to four-seconds. Each puff offered 5 to 11 mg of consumable liquid and 2 to 6 mg collected afterward.

High Voltage Puffs Equal Higher Cancer Risk

The findings revealed at low voltages, no formaldehyde-releasing agents were detected. At higher voltages, a greater amount of formaldehyde was released, amounts far higher than seen in conventional cigarettes.

An e-cigarette user will inhale 14.4 milligrams of formaldehyde per day; a user of traditional cigarettes will inhale about 3 milligrams for each pack of 20 cigarettes. Researchers called this a conservative estimate, since the machine did not collect all the aerosolized liquid or gas-phase formaldehyde.

At this rate, e-cigarette users face 5 to 15 times the risk of cancer as that of long-term smoking, study authors say. The concern rises because researchers don’t exactly know how hemiacetals behave in the respiratory tract, which may be different from regular cigarettes, possibly depositing more efficiently.

Formaldehyde inhaled as a gas is associated with a higher risk of leukemia and nasopharyngeal cancer, which affect the upper part of the throat.

The findings of Japanese study also highlighted the risk of cancer posed by e-cigarettes. The research concluded many brands of e-cigarettes release ten times the amount of cancer-causing agents compared to tobacco cigarettes.

Researchers calculated the lifetime risk of developing a formaldehyde related cancer from e-cigarettes versus traditional cigarettes and found the risk with e-cigarettes was 1 in 200 compared to 1 in 1,000 with cigarettes.

Another recent study revealed smokers are relying on e-cigarettes more as a device to quit smoking traditional cigarettes, despite concerns about whether e-cigarettes may be a threat to consumer health.

Critics argue the findings of the new study may be misconstrued and insist e-cigarettes are safer than traditional cigarettes since they also contain nearly 70,000 other toxic chemicals that place smokers at a greater risk of developing cancer.

Recently a group of senators issued a letter to the FDA urging the agency to begin regulating e-cigarettes by placing stricter warnings about the potential health risks. The letter called on the FDA to finalize regulations on the products, a promise that has been promised since 2010.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic and Rybelsus Side Effects Led to Ileus, Nausea and Vomiting, Lawsuit Alleges
Ozempic and Rybelsus Side Effects Led to Ileus, Nausea and Vomiting, Lawsuit Alleges (Posted 2 days ago)

A Kentucky man's lawsuit claims Ozempic and Rybelsus side effects led to multiple trips to the emergency room due to nausea, vomiting and other reactions to his intestinal muscles being unable to push food through his digestive tract.

Multi-Day Suboxone Lawsuit Status Conference Being Held To Review Census Protocol and Procedures
Multi-Day Suboxone Lawsuit Status Conference Being Held To Review Census Protocol and Procedures (Posted 2 days ago)

Lawyers will be meeting with the MDL judge presiding over all Suboxone tooth decay lawsuits on October 4 and 5, 2024, to finalize information needed to select a group of representative cases for bellwether discovery and trial.

Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure
Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure (Posted 3 days ago)

Lawyers have reached a confidential settlement agreement to resolve tens of thousands of Bard hernia mesh lawsuits after six years of litigation, but individuals must still agree to participate and settle their claims.